Approval was based on the pivotal Phase 3 CodeBreaK 300 study.

Designed to increase throughput, decrease COGS, and reduce batch failures.

Offers first-opening indication, oxygen and light protection, and can include an RFID chip for drug traceability and inventory management.

Ravensburg, January 14, 2025: Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has ...

Caris Life Sciences, a provider of molecular profiling and artificial intelligence (AI)-driven solutions for cancer treatment ...

Under the agreement, AGC Biologics will manufacture the lentiviral vector used to produce lete-cel, an engineered T-cell ...

IDT Biologika, a global contract development and manufacturing organization (CDMO), has appointed Federico Pollano as Chief ...

The treatment will be stockpiled and available for rapid deployment as part of the SNS CHEMPACK program.

CGMP cytokines now available for Charles River’s Cell Therapy Flex Platform.

Emmes Group, a specialty tech and AI-enabled global contract research organization (CRO), has appointed Germaine Gross as ...

Lyndra Therapeutics, a clinical-stage biopharmaceutical company, has entered a strategic collaboration with Thermo Fisher ...

Almac Sciences, a member of the Almac Group, has invested £500,000 in state-of-the-art instrumentation within its spectroscopy labs at its global headquarters in Craigavon, Northern Ireland. Almac has ...